The largest database of trusted experimental protocols

6 aminocaproic acid 6 aca

Manufactured by Merck Group

6-aminocaproic acid (6-ACA) is a chemical compound used as a laboratory reagent. It functions as an inhibitor of fibrinolysis, the process that breaks down blood clots. 6-ACA is commonly used in research applications that involve the study of blood coagulation and related processes.

Automatically generated - may contain errors

2 protocols using 6 aminocaproic acid 6 aca

1

Generation of Engineered Muscle Bundles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Muscle bundles were generated as previously described by Bakooshli et al. with minor adjustments22 (link). Before generation of muscle bundles, bone-shaped PDMS chambers were sterilized and pre-treated with 1% Pluronic F-127 (Sigma-Aldrich) for 1 h at room temperature. Confluent myoblast cultures were dissociated with TrypLE Express Enzyme (Gibco) reagent and 3 × 10^5 cells were used per muscle bundle. Cells were incubated on ice and combined with an ice-cold hydrogel mixture consisting of 4 mg/ml bovine fibrinogen (Sigma-Aldrich) and 20% Growth Factor Reduced Matrigel (Corning). Before loading the cell/hydrogel mixture into a bone-shaped PDMS chamber, 0.8 units of Bovine Thrombin (Sigma-Aldrich) were added to initiate fibrinogen polymerization. Loaded PDMS chambers were incubated for 30 min at 37 °C and after polymerization muscle bundles were kept in normal proliferation medium containing 1.5 mg/ml 6-aminocaproic acid (6-ACA) (Sigma-Aldrich). After 2 days, differentiation was induced by changing medium to differentiation medium (DMEM high glucose (Gibco), 2% horse serum (Gibco), 1% Penicillin G (Sigma-Aldrich) and 2 mg/ml 6-Aca). Seven days after differentiation muscle bundles were fixed overnight at 4 °C with 2% PFA. Muscle bundles were stored in PBS at 4 °C.
+ Open protocol
+ Expand
2

3D Tissue-Engineered Skeletal Muscle Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
3D-TESMs were generated in an Ecoflex Replica mold using a 15-µl hydrogel-cell mixture containing 2 mg/ml fibrinogen (Sigma-Aldrich), 20% Matrigel growth factor reduced (±10 mg/ml, Corning), 240,000 MPCs, and 0.8 units/ml bovine thrombin (Sigma-Aldrich) [15 ]. For the delivery of lentiviral particles, viral concentrates were transferred to the hydrogel-cell mixture before pipetting the mixture into the PDMS chamber or to the culture medium. The 3D-TESMs were incubated for 20 min at 37 °C before the addition of proliferation medium supplemented with 1.5 mg/ml 6-aminocaproic acid (6-ACA) (Sigma-Aldrich) and switched to differentiation medium supplemented with 2 mg/ml 6-ACA after 48 h. 3D-TESMs were cultured on a 65-rpm shaking platform at 37 °C/5% CO2, and half of the differentiation medium was refreshed every 48 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!